|

Clinical Cohort Study - TRUST

RECRUITINGSponsored by Universitätsklinikum Hamburg-Eppendorf
Actively Recruiting
SponsorUniversitätsklinikum Hamburg-Eppendorf
Started2021-03-17
Est. completion2026-09-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05521451

Summary

The "Long-term Outcome and Predictors for Recurrence after Medical and Interventional Treatment of Arrhythmias at the University Heart Center Hamburg" (TRUST) study is an investor-initiated, single-center, prospective clinical cohort study including patients treated with cardiac arrhythmias or at high risk for cardiac arrhythmias. The design enables prospective, low-threshold, near complete inclusion of patients with arrhythmias treated at the UHZ. Collection of routine follow-up data, detailed procedural information and systematic biobanking will enable precise and robust phenotyping.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Cardiac arrhythmia, including congenital cardiac arrhythmia diagnosed at baseline or high risk for cardiac arrhythmia
* Age ≥ 18 years
* Written informed consent
* Ability to provide written informed consent in accordance with Good Clinical Practice and local legislation

Exclusion Criteria:

* Insufficient knowledge of the German language to understand study documents and interview without translation
* Physical or psychological incapability to cooperate in the investigation

Conditions13

Arrhythmias, CardiacArrhythmogenic Right Ventricular DysplasiaAtrial CardiomyopathyAtrial FibrillationAtrial FlutterAtrial TachycardiaBrugada SyndromeCatecholaminergic Polymorphic Ventricular TachycardiaHeart DiseaseLong QT Syndrome

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.